The low-dose dexamethasone suppression test in fibromyalgia

Journal of Psychosomatic Research

Volumn 62, Issue 1, 2007, Pages 85-91

  Wingenfeld, Katja ^a,b   Wagner, Dieter ^a   Schmidt, Iris ^a   Meinlschmidt, Gunther ^a,c   Hellhammer, Dirk H ^a   Heim, Christine ^a,d  

^a UNIVERSITY OF TRIER   (Germany)

^b Department of Psychiatry and Psychotherapy Bethel ^*  (Germany)

^c UNIVERSITY OF BASEL   (Switzerland)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dexamethasone; Fibromyalgia; Hypothalamic pituitary adrenal; Stress

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE;

ADULT; ANXIETY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DEXAMETHASONE SUPPRESSION TEST; DRUG BLOOD LEVEL; DRUG DETERMINATION; FATIGUE; FEMALE; FIBROMYALGIA; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOW DRUG DOSE; PAIN; STRESS;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANXIETY; BIOFEEDBACK (PSYCHOLOGY); DEPRESSION; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FATIGUE; FEMALE; FIBROMYALGIA; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MIDDLE AGED; PAIN; PITUITARY-ADRENAL SYSTEM;

EID: 33845564948     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2006.06.006     Document Type: Article

References (66)

1. Wolfe F., Smythe H., Yunus M., Bennett R., Bombardier C., Goldenberg D., et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33 (1990) 160-172
2. Wolfe F., Ross K., Anderson J., Russell I., and Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38 (1995) 19-28
3. Wolfe F. Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am 15 (1989) 1-18
4. Heim C., Ehlert U., and Hellhammer D. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 25 (2000) 1-35
5. Crofford L., Pillemer S., Kalogeras K., Cash J., Michelson D., Kling M., et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 37 (1994) 1583-1592
6. McCain G., and Tilbe K. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol Suppl 19 (1989) 154-157
7. Griep E., Boersma J., Lentjes E., Prins A., van der Korst J., and de Kloet E. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol 25 (1998) 1374-1381
8. Griep E., Boersma J., and de Kloet E. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 20 (1993) 469-474
9. Riedel W., Layka H., and Neeck G. Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones. Z Rheumatol 57 Suppl 2 (1998) 81-87
10. Calis M., Gokce C., Ates F., Ulker S., Izgi H., Demir H., et al. Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J Endocrinol Invest 27 (2004) 42-46
11. Kirnap M., Colak R., Eser C., Ozsoy O., Tutus A., and Kelestimur F. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome. Clin Endocrinol (Oxf) 55 (2001) 455-459
12. Carroll B. The dexamethasone suppression test for melancholia. Br J Psychiatry 140 (1982) 292-304
13. Ferraccioli G., Cavalieri F., Salaffi F., Fontana S., Scita F., Nolli M., et al. Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain). J Rheumatol 17 (1990) 869-873
14. Ataoglu S., Ozcetin A., Yildiz O., and Ataoglu A. Evaluation of dexamethasone suppression test in fibromyalgia patients with or without depression. Swiss Med Wkly 133 (2003) 241-244
15. Yehuda R., Giller E., Southwick S., Lowy M., and Mason J. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry 30 (1991) 1031-1048
16. Yehuda R., Southwick S., Krystal J., Bremner D., Charney D., and Mason J. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry 150 (1993) 83-86
17. Yehuda R., Boisoneau D., Lowy M., and Giller E. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry 52 (1995) 583-593
18. Yehuda R., Halligan S., Grossman R., Golier J., and Wong C. The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder. Biol Psychiatry 52 (2002) 393-403
19. Yehuda R., Golier J., Halligan S., Meaney M., and Bierer L. The ACTH response to dexamethasone in PTSD. Am J Psychiatry 161 (2004) 1397-1403
20. Gaab J., Huster D., Peisen R., Engert V., Schad T., Schurmeyer T., et al. Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom Med 64 (2002) 311-318
21. Heim C., Ehlert U., Hanker J., and Hellhammer D. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Psychosom Med 60 (1998) 309-318
22. Wittchen H., Zaudig M., and Fydrich T. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. SKID-I (1997), Hogrefe, Goettingen
23. Zung W. Depression status inventory and self-rating depression scale. In: Collegium Internationale Psychiatriae Scalarum (CIPS) (Ed). Internationale Skalen für Psychiatrie (1986), Beltz, Weinheim
24. Laux L., Glanzmann P., Schaffner P., and Spielberger C. Das State-Trait-Angstinventar. Theoretischen Grundlagen und Hansanweisung (1981), Beltz, Weinheim
25. Ehlers A., Steil R., and Foa E. Deutsche Übersetzung der Posttraumatic Stress Diagnostic Scale (PDS) (1996), University, Warneford Hospital, Department of Psychiatry, Oxford
26. Chalder T., Berelowitz G., Pawlikowska T., Watts L., Wessely S., Wright D., et al. Development of a fatigue scale. J Psychosom Res 37 (1993) 147-153
27. Fahrenberg J. Die Freiburger Beschwerdeliste (FBL) (1994), Hogrefe, Goettingen
28. Bremner J., Vermetten E., and Mazure C. Development and preliminary psychometric properties of an instrument for the measurement of childhood trauma: the Early Trauma Inventory. Depress Anxiety 12 (2000) 1-12
29. Resnick H., Kilpatrick D., Dansky B., Saunders B., and Best C. Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women. J Consult Clin Psychol 61 (1993) 984-991
30. Kanner A., Coyne J., Schaefer C., and Lazarus R. Comparison of two modes of stress measurement: daily hassles and uplifts versus major life events. J Behav Med 4 (1981) 1-39
31. Sarason I., Johnson J., and Siegel J. Assessing the impact of life changes: development of the Life Experiences Survey. J Consult Clin Psychol 46 (1978) 932-946
32. Schulz P., and Schlotz W. Trierer Inventar zur Erfassung von chronischem Stress (TICS). Skalenkonstruktion, teststatistische Überprüfung und Validierung der Skala Arbeitsüberlastung. Diagnostika 45 (1999) 8-19
33. Schulz P., Jansen L., and Schlotz W. Stressreaktivität: theoretisches konzept und messung. Diagnostica 51 (2005) 124-133
34. Sapolsky R. Glucocorticoids, stress, and their adverse neurological effects: relevance to aging. Exp Gerontol 34 (1999) 721-732
35. Giordano R., Bo M., Pellegrino M., Vezzari M., Baldi M., Picu A., et al. Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade. J Clin Endocrinol Metab 90 (2005) 5656-5662
36. Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology 30 (2005) 1-10
37. Lindheim S., Legro R., Bernstein L., Stanczyk F., Vijod M., Presser S., et al. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am J Obstet Gynecol 167 (1992) 1831-1836
38. Kudielka B., Schmidt-Reinwald A., Hellhammer D., and Kirschbaum C. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment. Neuroendocrinology 70 (1999) 422-430
39. Kudielka B., and Kirschbaum C. Sex differences in HPA axis responses to stress: a review. Biol Psychol 69 (2005) 113-132
40. Cassidy F., Ritchie J., Verghese K., and Carroll B. Dexamethasone metabolism in dexamethasone suppression test suppressors and nonsuppressors. Biol Psychiatry 47 (2000) 677-680
41. Stokes P., Sikes C., Lasley B., and Stoll P. HPA hyperactivity with increased plasma cortisol affects dexamethasone metabolism and DST outcome. J Psychiatr Res 36 (2002) 417-421
42. Yehuda R. Current status of cortisol findings in post-traumatic stress disorder. Psychiatr Clin North Am 25 (2002) 341-368
43. Newport D., Heim C., Bonsall R., Miller A., and Nemeroff C. Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol Psychiatry 55 (2004) 10-20
44. Loose D., Do Y., Chen T., and Feldman D. Demonstration of glucocorticoid receptors in the adrenal cortex: evidence for a direct dexamethasone suppressive effect on the rat adrenal gland. Endocrinology 107 (1980) 137-146
45. Kontula K., Pomoell U., Gunsalus G., and Pelkonen R. Glucocorticoid receptors and responsiveness of normal and neoplastic human adrenal cortex. J Clin Endocrinol Metab 60 (1985) 283-289
46. Engel C., Walker E., Engel A., Bullis J., and Armstrong A. A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain. J Psychosom Res 44 (1998) 203-207
47. Bornstein S., and Chrousos G. Clinical review 104: adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metab 84 (1999) 1729-1736
48. Whitworth E., Kosti O., Renshaw D., and Hinson J. Adrenal neuropeptides: regulation and interaction with ACTH and other adrenal regulators. Microsc Res Tech 61 (2003) 259-267
49. Aaron L., Bradley L., Alarcon G., Alexander R., Triana-Alexander M., Martin M., et al. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum 39 (1996) 436-445
50. Amir M., Kaplan Z., Neumann L., Sharabani R., Shani N., and Buskila D. Posttraumatic stress disorder, tenderness and fibromyalgia. J Psychosom Res 42 (1997) 607-613
51. Walker E., Keegan D., Gardner G., Sullivan M., Katon W., and Bernstein D. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: I. Psychiatric diagnoses and functional disability. Psychosom Med 59 (1997) 565-571
52. Epstein S., Kay G., Clauw D., Heaton R., Klein D., Krupp L., et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 40 (1999) 57-63
53. Roy-Byrne P., Smith W., Goldberg J., Afari N., and Buchwald D. Post-traumatic stress disorder among patients with chronic pain and chronic fatigue. Psychol Med 34 (2004) 363-368
54. Hudson J., Goldenberg D., Pope H., Keck P., and Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 92 (1992) 363-367
55. Elzinga B., Schmahl C., Vermetten E., van Dyck R., and Bremner J. Higher cortisol levels following exposure to traumatic reminders in abuse-related PTSD. Neuropsychopharmacology 28 (2003) 1656-1665
56. Heim C., Newport D., Heit S., Graham Y., Wilcox M., Bonsall R., et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 284 (2000) 592-597
57. Heim C., Newport D., Bonsall R., Miller A., and Nemeroff C. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry 158 (2001) 575-581
58. Boisset-Pioro M., Esdaile J., and Fitzcharles M. Sexual and physical abuse in women with fibromyalgia syndrome. Arthritis Rheum 38 (1995) 235-241
59. Taylor M., Trotter D., and Csuka M. The prevalence of sexual abuse in women with fibromyalgia. Arthritis Rheum 38 (1995) 229-234
60. Walker E., Keegan D., Gardner G., Sullivan M., Bernstein D., and Katon W. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosom Med 59 (1997) 572-577
61. Imbierowicz K., and Egle U. Childhood adversities in patients with fibromyalgia and somatoform pain disorder. Eur J Pain 7 (2003) 113-119
62. Dailey P., Bishop G., Russell I., and Fletcher E. Psychological stress and the fibrositis/fibromyalgia syndrome. J Rheumatol 17 (1990) 1380-1385
63. Uveges J., Parker J., Smarr K., McGowan J., Lyon M., Irvin W., et al. Psychological symptoms in primary fibromyalgia syndrome: relationship to pain, life stress, and sleep disturbance. Arthritis Rheum 33 (1990) 1279-1283
64. McLean S., Williams D., Harris R., Kop W., Groner K., Ambrose K., et al. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum 52 (2005) 3660-3669
65. Weissbecker I., Floyd A., Dedert E., Salmon P., and Sephton S. Childhood trauma and diurnal cortisol disruption in fibromyalgia syndrome. Psychoneuroendocrinology 31 (2006) 312-324
66. Alexander R., Bradley L., Alarcon G., Triana-Alexander M., Aaron L., Alberts K., et al. Sexual and physical abuse in women with fibromyalgia: association with outpatient health care utilization and pain medication usage. Arthritis Care Res 11 (1998) 102-115